R&D Systems™ Recombinant Human cIAP-1 (HIAP-2) Protein

Description

Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Inhibition Activity

Measured by its ability to inhibit DEVD-AFC cleavage activity in cell extracts activated by addition of cytochrome c and dATP. The IC50 for this effect is 25-1000 nM. Optimal dilutions should be determined by each laboratory for each application.

Specifications

• Accession Number: Q13490
• For Use With (Application): Inhibition Assay
• Formulation: Supplied as a 0.2 μm filtered solution in HEPES, NaCl, DTT and Glycerol.
• Gene ID (Entrez): 329
• Molecular Weight (g/mol): M.W. (Observed): 68 kDa, reducing conditions; M.W. (theoretical): 72 kDa
• Name: cIAP-1/HIAP-2
• Quantity: 50 μg
• Source: E. coli-derived human cIAP-1/HIAP-2 protein ATVID 10-His tag SIEGRA Human cIAP-1 (His2-Ser618) (N-terminus) Accession # Q13490 (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -70°C as supplied. 3 months, -70°C under sterile conditions after opening.
• Gene Symbol: BIRC2
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: >85%, by SDS-PAGE under reducing conditions and visualized by silver stain
• Protein: cIAP-1/HIAP-2